News By Tag
News By Location
Second Human Clinical Study Confirms kollaGen I.V.X. HEM™ Efficacy with Only 500mg/daily
Certified Nutratraceuticals is pleased to announce the positive results of the 60 day Human Clinical Study for the efficacy of the supplement kollaGen I.V.X. HEM™ "HYDROLYZED COLLAGEN" AS SEEN ON DR. OZ.
This Hydrolyzed Collagen Egg Membrane is a protein characterized by a developmentally advanced proportion of collagen that is effectively matched to skin and other tissues. It elevates the fibroblast activity and promotion stimulating their growth and strengthening the matrix. A fibroblast is a type of cell that synthesizes the extracellular matrix and collagen.
The Hydrolyzed Egg Membrane contains several bacteriolytic enzymes and other components that alter the effect of heat-resistant gram-positive and gram-negative pathogens increasing the skin's ability to withstand a variety of inflammatory processes. Hydrolyzed Egg Membrane contains very powerful compounds including: elastin, collagen, desmosine, isodesmosine and transforming growth factor-B and a complex of glycosaminoglycans such as glucosamine, chondroitin, and hyaluronic acid and other effective compounds. The compounds are proven to be of use for pain management associated with joint disease due to the distinctive concentration of the potent, natural compounds in the Hydrolyzed Egg Membrane. Therefore, in this trial our goal was to examine the effectiveness of the substance on patients with symptoms associated with Osteoarthritis and related inflammatory diseases/conditions which could prove to be far reaching.
For this study we chose 20 patints' ages 21 years to 80 years (10 males / 10 females ) with confirmed joint damage, cartilage injuries, and skin disorders, diagnosed with imaging/scoping with low to high pain scales. The optimal dosage administered is 500mg. daily dietary supplement taken with citric juice on an empty stomach.
Significant Findings and Positive Clinical Responses from Study - Respondents/
- No patients during the trial voluntarily withdrew or were requested to discontinue the Hydrolyzed Egg Membrane capsules.
- The pain scale before commencement of the trial averaged out at 90% for moderate to severe and 10% for low to moderate pain (based on a scale of 1-10 - 1 being the lowest, 10 being the highest),
- 100% of participants could not walk/jog 100 meters without pain occuring in some form.
- 100% of participants at times had pain and inflammation following any activities such as sports or brisk walking.
- 2 senior participants (>65 years of age) reported that their mobility increased that led to more independence.
- 5 Participants with osteoarthritis reported less pain, more mobility and better range of motion within 10 days into trial.
- Arthritis and amputee participant noted a decrease in inflammation around the distal area of the amutation within 6 days 45% and by 16 days an overall imporvement of 65%.
- Participant with the amputation noticed that a chronic (<3 months) ulceration and dermatitis at the operative site of the stump had healed up 90% at the end of the 60 day trial.
- 2 Participants with pot bone fractures and arthritic like symptoms at the break sites noted 60% reduction in pain and associated symptoms.
- 1 participant with arthritis and external/internal anatomical damage noted a decrease in site inflammation of 40% and range of motion, pain and general usage increased to 60% by the end of the trial. This individual also had a quality of life improvement by over 50% due to a reduction in her Fibromyalgia.
- 100% of the participants in the trial patients on some form of analgesic or glucosamine and chondroitin found that in general the oral supplementation of Hydrolyzed Egg Membrane was far superior in treating symptoms of pain and inflammation.
- Blood Glucose of uncontrolled diabetes patients equalized to within normal levels after 34 days for one and the other at 40 days on the trial. It should be notied that the uncontrolled diabetes condition of the 2 patients had been that way for >1.5 years.
Arthritis patient with multiple affected areas (knee, elbow, hip, and spine) with extremely limited activity even with aid of a walker significantly improved overall. The participant clearly reported that she could not walk around the indoor shopping mall, now is walking 3 days a week. She could also navigate daily functions without assistance, cook, cleaning the house, and personal care.
Targeted Clincal Response Results:
Supplementation with Hydrolyzed Egg Membrane produced a significant treatment response at seven days for flexibility (74.5% increase; P=0.035) and at 60 days for general pain (91.7% reduction; P=0.006), flexibility (70.6% increase; P=0.006) and range of motion associated pain (77.3% reduction; P=0.020). There were no adverse events reported during the study and the treatment was reported to be well tolerated by study participants.
The reporting of results from this human clinical trial demonstrates that Hydrolyzed Egg Membrane is a practical treatment option for the overall management of Joint and Connective Tissue Disease, Symptoms, and related superfluous side effects. The study in Particular noted an excellent response for participants suffering from Osteoarthritis. A clinical trial dosage of 500mg taken once per day had a rapid response effect within a 7 day period and over 70% at day 14. The Participants' clinical picture continued upward to 60 days into the trial receiving the full weight of the substances capabilities reduce pain, inflammation, and swelling to reginal swelling to some degree. The participant's quality of life had increased upwards of 80% after the conclusion of the trial. We found it very intriguing that the blood glucose levels of the 2 new perticipants started to normalize after half way into the trial. This is an exciting discovery and clearly needs a further look to establish how great the margin of treatability actually is. Hydrolyzed egg membrane should clearly be a viable option for the treatment/management of Joint and Connective Tissue Disease/Disorders, and marked pain syndrome with a substantial reduction of symptoms. We can state that our participants and clinical team exhibited or observed no side effects or allergens throughout the trial of 60 days indicating not only eggicacy but safety as well.
The Human Clinical Trial performed by Morton Scientific Group of Cambridge, Ontario, Canada and overseen by quealified Medical Doctors. Certified Nutraceuticals supplies the world market with Hydrolyzed kollaGen I.V.X HEM™ in bulk powder which is manufactured at FDA-USDA approved facility and proudly promotes the products as Made in USA.